Clinical and demographic characteristics and two-year efficacy and safety data of 508 multiple sclerosis patients with fingolimod treatment (vol 60, pg 23, 2023)

Basit Öğe Kaydı
dc.contributor.authorTerzi, Murat
dc.contributor.authorHelvacı, Elif Merve
dc.contributor.authorŞen, Sedat
dc.contributor.authorBoz, Cavit
dc.contributor.authorÇilingir, Vedat
dc.contributor.authorAkçalı, Aylin
dc.contributor.authorBeckmann, Yeşim
dc.contributor.authorUzunköprü, Cihat
dc.contributor.authorSözer, Gökçe
dc.contributor.authorTerzi, Yüksel
dc.date.accessioned2023-08-25T12:00:34Z
dc.date.available2023-08-25T12:00:34Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü, Farmasötik Teknoloji Ana Bilim Dalı
dc.description.abstractCopyright of Archives of Neuropsychiatry / Noropsikiatri Arsivi is the property of Turkish Association of Neuropsychiatry and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
dc.identifier.citationTerzi, M., Helvacı, E. M., Şen, S., Boz, C., Çilingir, V., Akçalı, A. ... Terzi, Y. (2023). Clinical and demographic characteristics and two-year efficacy and safety data of 508 multiple sclerosis patients with fingolimod treatment (vol 60, pg 23, 2023). Archives of Neuropsychiatry, 60(2), 190-190. https://dx.doi.org/10.29399/npa.28499
dc.identifier.doi10.29399/npa.28499
dc.identifier.endpage190
dc.identifier.issn1300-0667
dc.identifier.issn1309-4866
dc.identifier.issue2
dc.identifier.pmid36911568
dc.identifier.startpage190
dc.identifier.urihttps://dx.doi.org/10.29399/npa.28499
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11366
dc.identifier.volume60
dc.identifier.wos001021642100017en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.institutionauthorSözer, Gökçe
dc.language.isoen
dc.publisherTurkish Neuropsychiatric Society
dc.relation.ispartofArchives of Neuropsychiatryen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectEfficacy
dc.subjectFingolimod
dc.subjectMultiple Sclerosis
dc.subjectSafety
dc.titleClinical and demographic characteristics and two-year efficacy and safety data of 508 multiple sclerosis patients with fingolimod treatment (vol 60, pg 23, 2023)
dc.typeOther

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Sozer-Gokcee-2023.pdf
Boyut:
75.32 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Eczacılık Fakültesi Diğer Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu